CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 129 enrolled
Drug / intervention
Partially Covered Wallstent +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01047332
NCT01047332N/ACompleted

A Randomized Trial Comparing the Uncovered to the Covered Wallstent in the Palliation of Malignant Bile Duct Strictures

Brigham and Women's Hospital·interventional·Posted Jan 12, 2010·Updated Apr 11, 2017

In Brief

A clinical study evaluating Partially Covered Wallstent and Uncovered Wallstent for Inoperable Tumors of the Bile Duct. Completed, enrolled 129 participants.

Detailed Summary

The purpose of the study is to determine the best management of bile duct narrowing (stricture) due to inoperable tumors. The bile duct is a tube that carries bile formed in the liver to the small bowel to digest fats. Tumors around the bile duct can compress the duct causing pain, jaundice (yellow skin and eyes), itchy skin and fever.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 12, 2010
Enrollment StartOct 1, 2002
Primary CompletionMay 1, 2008
Study CompletionNov 1, 2009
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 16.5 years ago

Interventions

Partially Covered Wallstentdevice

Partially covered wallstent

Uncovered Wallstentdevice

Uncovered wallstent